A survey screen for prediction of apnea

Recognition and consequences of obstructive sleep apnea hypopnea syndrome

There is a growing recognition of sleep-disordered breathing (SDB) in patient groups and in the general population. This article reviews issues related to recognizing the disorder, including the problems of relying on narrowly defined polysomnographic data for case findings and for assessment of disease severity. The distributions of symptoms and physiologic measurements of SDB in the population and their inter-relationships are reviewed. The epidemiological data that address risk factors and consequences of sleep apnea hypopnea syndrome (SAHS) also are discussed, with recommendations regarding recognition priorities.

Diagnostic techniques in obstructive sleep apnea

Only in the last 25 years has sleep apnea been recognized as a very common disorder and important cause of mortality. Overnight, attended polysomnography remains the reference diagnostic tool for sleep apnea, although the technology for diagnosis continues to evolve rapidly. In many instances, screening and ambulatory monitoring devices can provide similar, clinically relevant information, but larger validation studies including long-term clinical outcomes are necessary.

Indications for positive airway pressure treatment of adult obstructive sleep apnea patients: a consensus statement

We developed a short-length document that clearly delineates a prudent approach to and criteria for reimbursement of positive airway pressure (PAP) costs for the treatment of obstructive sleep apnea (OSA). Treatment modalities for OSA with PAP include continuous positive airway pressure, bilevel or variable PAP, and autotitrating PAP. This guidance on the appropriate criteria for PAP use in OSA is based on widely acknowledged peer-reviewed studies and widely accepted clinical practice. These criteria reflect current opinion on the appropriate clinical management of OSA in lieu of data pending from the Sleep Heart Health Study and upcoming outcome studies. This document is not intended to provide a complete review and analysis of the OSA clinical literature. The key to the success of this document is to foster consensus within and outside the clinical sleep community by providing a common sense and easily understood approach to the treatment of OSA with PAP.

Comparison of the severity of sleep-disordered breathing in Asian and Caucasian patients seen at a sleep disorders center

Race can be considered a risk factor for sleep-disordered breathing (SDB), with higher prevalences and greater severity of the disorder documented among persons of certain racial groups compared with others. Based on clinical observation, it was hypothesized that, other risk factors being equal, Asian patients with SDB have greater severity of their illness compared to Caucasian patients. A cross-sectional study was conducted at a sleep disorders clinic involving 105 Asian patients diagnosed as having SDB after undergoing polysomnography and 99 similarly diagnosed Caucasian patients matched for the following variables: age, gender and body mass index (BMI). The main outcome measure of interest was objective assessment of severity based on polysomnographic data of respiratory disturbance index (RDI) and minimum oxygen saturation (SaO2) during sleep. Symptom scores between patients of the two racial groups were also compared. There were significantly larger proportions of Asians compared to Caucasians with severe obstructive sleep apnea (OSAS) as defined by respiratory disturbance index (RDI) > or = 50 (25.0% vs 11.1%; P = 0.0288) or minimum oxygen saturation (SaO2) < or = 69% (20.6% vs 4.2%; P = 0.0113). The mean minimum SaO2 was significantly lower (P = 0.0001) while the mean (log transformed) esophageal pressure (Pes) value was significantly higher (P = 0.0090) in the Asian group. Logistic regression analysis showed that race was associated with severe SDB (RDI > or = 50) independent of age, sex and BMI. The estimated odds ratio for Asians having severe OSAS compared with Caucasians was 2.51 [95% Confidence Interval (CI) 0.98-6.64]. There was no significant difference in the severity of questionnaire-based symptoms of snoring, apneas during sleep and the median Epworth scores between Asian and Caucasian patients. Based on objective polysomnographic results, Asian patients with OSAS have greater severity of their illness compared to Caucasian patients matched for age, gender and BMI. There was, however, no significant difference in severity of questionnaire-based symptoms between Asian and Caucasian patients with SDB.

Identification of obstructive sleep apnea in patients who snore

As the field of sleep medicine has evolved, the clinical implications of obstructive sleep apnea (OSA) in snoring patients have become well accepted. Recent advances in surgical therapy for snoring allow otolaryngologists to offer simple outpatient treatment to patients with this problem. However, because the incidence of OSA in snorers seeking medical attention is unknown, the appropriate pretreatment evaluation of these patients is a subject of continued debate. Ninety-four snoring patients were recruited for a study to determine the incidence of OSA in this highly selected population. Subjects answered an extensive sleep questionnaire to determine factors that might suggest a diagnosis of OSA. Level III ambulatory sleep studies were performed on each participant. The incidence of OSA in this group was 72% (42% severe and 30% mild to moderate). Twenty of the subjects with OSA also underwent formal level I sleep studies, and the diagnosis of OSA was confirmed in each instance. Although there was a relationship between body mass index and OSA and certain questions correlated with OSA, the sensitivity and specificity of these data alone or in combination were too low to recommend their use in lieu of a formal sleep study. Given the remarkably high incidence of OSA in this group, which may reflect that seen by otolaryngologists who treat snoring, a sleep study should be performed to diagnose OSA and institute therapy for this condition. Level III ambulatory monitoring devices may be the most cost-effective alternative for evaluating this high-risk population.

Recognition and consequences of obstructive sleep apnea hypopnea syndrome

There is a growing recognition of sleep-disordered breathing (SDB) in patient groups and in the general population. This article reviews issues related to recognizing the disorder, including the problems of relying on narrowly defined polysomnographic data for case findings and for assessment of disease severity. The distributions of symptoms and physiologic measurements of SDB in the population and their inter-relationships are reviewed. The epidemiological data that address risk factors and consequences of sleep apnea hypopnea syndrome (SAHS) also are discussed, with recommendations regarding recognition priorities.